Your browser doesn't support javascript.
loading
Dietary supplementation with probiotics promotes weight loss by reshaping the gut microbiome and energy metabolism in obese dogs.
Kang, Anna; Kwak, Min-Jin; Lee, Daniel Junpyo; Lee, Jeong Jae; Kim, Min Kyu; Song, Minho; Lee, Minjee; Yang, Jungwoo; Oh, Sangnam; Kim, Younghoon.
Afiliación
  • Kang A; Department of Agricultural Biotechnology and Research Institute of Agriculture and Life Science, Seoul National University, Seoul, South Korea.
  • Kwak M-J; Department of Agricultural Biotechnology and Research Institute of Agriculture and Life Science, Seoul National University, Seoul, South Korea.
  • Lee DJ; Department of Agricultural Biotechnology and Research Institute of Agriculture and Life Science, Seoul National University, Seoul, South Korea.
  • Lee JJ; Institute of Agricultural Science and Technology, Kyungpook National University, Daegu, South Korea.
  • Kim MK; Division of Animal and Dairy Science, Chungnam National University, Daejeon, South Korea.
  • Song M; Division of Animal and Dairy Science, Chungnam National University, Daejeon, South Korea.
  • Lee M; Ildong Bioscience, Pyeongtaek-si, Gyeonggi-do, South Korea.
  • Yang J; Ildong Bioscience, Pyeongtaek-si, Gyeonggi-do, South Korea.
  • Oh S; Department of Functional Food and Biotechnology, Jeonju University, Jeonju, South Korea.
  • Kim Y; Department of Agricultural Biotechnology and Research Institute of Agriculture and Life Science, Seoul National University, Seoul, South Korea.
Microbiol Spectr ; 12(3): e0255223, 2024 Mar 05.
Article en En | MEDLINE | ID: mdl-38270436
ABSTRACT
Obesity and overweight among companion animals are significant concerns, paralleling the issues observed in human populations. Recent research has highlighted the potential benefits of various probiotics in addressing weight-related changes, obesity, and associated pathologies. In this study, we delved into the beneficial probiotic mechanisms in high-fat-induced obese canines, revealing that Enterococcus faecium IDCC 2102 (IDCC 2102) and Bifidobacterium lactis IDCC 4301 (IDCC 4301) have the capacity to mitigate the increase in body weight and lipid accumulation in obese canines subjected to a high-fat diet and hyperlipidemic Caenorhabditis elegans (C. elegans) strain VS29. Both IDCC 2102 and IDCC 4301 demonstrated the ability to reduce systemic inflammation and hormonal disruptions induced by obesity. Notably, these probiotics induced modifications in the microbiota by promoting lactic acid bacteria, including Lactobacillaceae, Ruminococcaceae, and S24-7, with concomitant activation of pyruvate metabolism. IDCC 4301, through the generation of bacterial short-chain fatty acids and carboxylic acids, facilitated glycolysis and contributed to ATP synthesis. Meanwhile, IDCC 2102 produced bacterial metabolites such as acetic acid and butyric acid, exhibiting a particular ability to stimulate dopamine synthesis in a canine model. This stimulation led to the restoration of eating behavior and improvements in glucose and insulin tolerance. In summary, we propose novel probiotics for the treatment of obese animals based on the modifications induced by IDCC 2102 and IDCC 4301. These probiotics enhanced systemic energy utilization in response to high caloric intake, thereby preventing lipid accumulation and restoring stability to the fecal microbiota. Consequently, this intervention resulted in a reduction in systemic inflammation caused by the high-fat diet.IMPORTANCEProbiotic supplementation affected commensal bacterial proliferation, and administering probiotics increased glycolysis and activated pyruvate metabolism in the body, which is related to propanate metabolism as a result of pyruvate metabolism activation boosting bacterial fatty acid production via dopamine and carboxylic acid specialized pathways, hence contributing to increased ATP synthesis and energy metabolism activity.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Probióticos / Microbioma Gastrointestinal Límite: Animals / Humans Idioma: En Revista: Microbiol Spectr Año: 2024 Tipo del documento: Article País de afiliación: Corea del Sur Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Probióticos / Microbioma Gastrointestinal Límite: Animals / Humans Idioma: En Revista: Microbiol Spectr Año: 2024 Tipo del documento: Article País de afiliación: Corea del Sur Pais de publicación: Estados Unidos